Furthermore, compared with the non‐steatosis group, the NAFLD and NASH group demonstrated substantially higher DDX17 expression (Figure 1A) in the quantification of IHC. The gene discussed is DDX17; the disease is metabolic dysfunction-associated steatotic liver disease.